OA (osteoarthritis) is a degenerative condition associated with obesity. A number of metabolic explanations have been proposed to explain the association between obesity and OA in non-weight-bearing joints; however, none of these hypotheses have been demonstrated empirically. In the present Hypothesis article, we recognize that obesity is associated with compromised gut mucosa, translocation of microbiota and raised serum LPS (lipopolysaccharide). The consequent activation of the innate immune response leads to increased serum titres of inflammatory mediators in obese patients, with both local and systemic markers of inflammation associated with onset and progression of OA. Furthermore, a number of workers have shown that articular cartilage repair is impaired by a range of inflammatory mediators, both in vitro and in vivo. We propose that metabolic endotoxaemia, caused by impaired gastric mucosa and low-grade chronic inflammation, may contribute to the onset and progression of OA in obese patients. This may account for the association between obesity and OA at non-weight-bearing joints which cannot be explained by biomechanical factors.
Does endotoxaemia contribute to osteoarthritis in obese patients?
- Views Icon Views
- Share Icon Share
David Metcalfe, Alison L. Harte, Mina Olga Aletrari, Nasser M. Al Daghri, Dara Al Disi, Gyanendra Tripathi, Philip G. McTernan; Does endotoxaemia contribute to osteoarthritis in obese patients?. Clin Sci (Lond) 1 December 2012; 123 (11): 627–634. doi: https://doi.org/10.1042/CS20120073
Download citation file: